U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H30N6O3
Molecular Weight 462.5441
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VISTUSERTIB

SMILES

CNC(=O)C1=CC=CC(=C1)C2=CC=C3C(N=C(N=C3N4CCOC[C@@H]4C)N5CCOC[C@@H]5C)=N2

InChI

InChIKey=JUSFANSTBFGBAF-IRXDYDNUSA-N
InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1

HIDE SMILES / InChI
Molecular Formula C25H30N6O3
Molecular Weight 462.5441
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:31:18 UTC 2023
Edited
by admin
on Sat Dec 16 10:31:18 UTC 2023
Record UNII
0BSC3P4H5X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VISTUSERTIB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
AZD2014
Code English
AZD-2014
Code English
BENZAMIDE, 3-(2,4-BIS((3S)-3-METHYL-4-MORPHOLINYL)PYRIDO(2,3-D)PYRIMIDIN-7-YL)-N-METHYL-
Systematic Name English
Vistusertib [WHO-DD]
Common Name English
VISTUSERTIB [JAN]
Common Name English
3-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide
Systematic Name English
vistusertib [INN]
Common Name English
VISTUSERTIB [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129825
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
NCI_THESAURUS C2201
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
Code System Code Type Description
SMS_ID
100000174944
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
USAN
EF-07
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
DRUG BANK
DB11925
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
NCI_THESAURUS
C88329
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
ChEMBL
CHEMBL1078983
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
FDA UNII
0BSC3P4H5X
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
PUBCHEM
25262792
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
INN
10158
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID20143584
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
CAS
1009298-59-2
Created by admin on Sat Dec 16 10:31:18 UTC 2023 , Edited by admin on Sat Dec 16 10:31:18 UTC 2023
PRIMARY
Related Record Type Details
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1
TARGET -> INHIBITOR
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2
TARGET -> INHIBITOR
Related Record Type Details
Structure of VISTUSERTIB
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966